NCT04584827: Evaluation of Lactate in Patients Undergoing Glial and Non Glial Mass Surgery With Craniotomy

NCT04584827
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must be scheduled to have a craniotomy
Exclusions: 
https://ClinicalTrials.gov/show/NCT04584827

Comments are closed.

Up ↑